2eft
From Proteopedia
(Difference between revisions)
Line 20: | Line 20: | ||
==About this Structure== | ==About this Structure== | ||
- | 2EFT is a | + | 2EFT is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2EFT OCA]. |
==Reference== | ==Reference== | ||
- | + | <ref group="xtra">PMID:17524982</ref><references group="xtra"/> | |
[[Category: Beta-ketoacyl-acyl-carrier-protein synthase I]] | [[Category: Beta-ketoacyl-acyl-carrier-protein synthase I]] | ||
[[Category: Escherichia coli]] | [[Category: Escherichia coli]] | ||
- | [[Category: Single protein]] | ||
[[Category: Alhamadsheh, M M.]] | [[Category: Alhamadsheh, M M.]] | ||
[[Category: Florova, G.]] | [[Category: Florova, G.]] | ||
Line 41: | Line 40: | ||
[[Category: Mechanism-based inhibitor]] | [[Category: Mechanism-based inhibitor]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Feb 17 11:21:11 2009'' |
Revision as of 09:21, 17 February 2009
Methanethiol-CYS 112 inhibition complex of E. coli ketoacyl synthase III (FABH) and Coenzyme A (high concentration (1.7mM) soak)
Template:ABSTRACT PUBMED 17524982
About this Structure
2EFT is a 2 chains structure of sequences from Escherichia coli. Full crystallographic information is available from OCA.
Reference
- Alhamadsheh MM, Musayev F, Komissarov AA, Sachdeva S, Wright HT, Scarsdale N, Florova G, Reynolds KA. Alkyl-CoA disulfides as inhibitors and mechanistic probes for FabH enzymes. Chem Biol. 2007 May;14(5):513-24. PMID:17524982 doi:10.1016/j.chembiol.2007.03.013
Page seeded by OCA on Tue Feb 17 11:21:11 2009
Categories: Beta-ketoacyl-acyl-carrier-protein synthase I | Escherichia coli | Alhamadsheh, M M. | Florova, G. | Komissarov, A A. | Musayev, F. | Reynolds, K A. | Sachdeva, S. | Scarsdale, N. | Wright, H T. | Alkyl-coa-disulfide | E. coli | Fatty acid biosynthesis | Half sites occupancy | Mechanism-based inhibitor